Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
69 studies found for:    BUTYRYLCHOLINESTERASE
Show Display Options
Rank Status Study
21 Completed A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease
Condition: Lewy Body Disease
Intervention: Drug: Cholinesterase Inhibitors (Rivastigmine, Aricept, Galantamine)
22 Completed To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.
Condition: Alzheimer's Disease
Intervention: Drug: Atorvastatin
23 Completed Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine, memantine
24 Recruiting Effect of Galantamine on Short-term Abstinence
Conditions: Treatment-seeking Smokers, Reporting Consumption of at Least 10 Cigarettes;   Per Day for at Least the Past 6 Months
Intervention: Drug: Galantamine Hydrobromide-ER
25 Recruiting Effect of Galantamine on Short-term Abstinence
Condition: Tobacco Use Disorder
Interventions: Drug: Galantamine;   Drug: Placebo
26 Recruiting Treatment of Residual Amblyopia With Donepezil
Condition: Amblyopia
Interventions: Drug: Donepezil;   Other: Patching
27 Completed Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: atomoxetine hydrochloride;   Drug: placebo
28 Completed Effects of Donepezil on Deficits Associated With Age-Related Decrease of Growth Hormone
Condition: Elderly
Intervention: Drug: Donepezil
29 Recruiting Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3
Condition: Spinal Muscular Atrophy Type 3
Intervention: Drug: Pyridostigmine Bromide
30 Unknown  CALM-AD
Condition: Alzheimer's Disease
Intervention: Drug: Donepezil
31 Recruiting Study to Evaluate the Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease
Condition: Mild to Moderate Alzheimer's Disease
Intervention: Drug: Rivastigmine Patch
32 Recruiting The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study
Condition: Alzheimer Disease
Interventions: Drug: MLC901;   Drug: Placebo
33 Completed
Has Results
A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED)
Condition: Alzheimer's Disease
Interventions: Drug: Comparator: Placebo 5mg (run in);   Drug: Donepezil 5 - 10 mg;   Drug: Comparator: Placebo 5-10 mg;   Drug: Donepezil 10 mg
34 Completed Efficacy of Rivastigmine in Patients With Down Syndrome
Condition: Down Syndrome
Intervention: Drug: Rivastigmine
35 Completed Huperzine A in Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: Huperzine A
36 Completed
Has Results
Use of Donepezil for Treatment of Cocaine Dependence
Condition: Cocaine Abuse and Dependence
Interventions: Drug: Donepezil, 5 mg daily;   Other: Oral Placebo
37 Completed Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects
Condition: Cocaine Addiction
Interventions: Drug: TV-1380 150 mg;   Drug: TV-1380 300 mg;   Drug: Placebo
38 Completed Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance
Condition: Biomarkers, Pharmacological
Interventions: Drug: Huperzine A;   Drug: Donepezil;   Drug: Galantamine;   Other: Placebo
39 Completed
Has Results
Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)
Condition: Parkinson's Disease Dementia
Interventions: Drug: Rivastigmine capsule;   Drug: Rivastigmine transdermal patch
40 Completed
Has Results
A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.